Loading data
CMMBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 2.33 m USD | 2.47 m USD | 4.39 m USD | 5.14 m USD | 3.31 m USD |
| Research and development expense | 5.83 m USD | 11.33 m USD | 18.38 m USD | 16.98 m USD | 6.33 m USD |
| Operating profit | -112 m USD | -103 m USD | — | — | — |
| Profit before tax | -9 m USD | -13.95 m USD | -24.22 m USD | -28.18 m USD | -12.48 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | -534 k USD | 0 USD |
| Net income (reported basis) | -9 m USD | -13.95 m USD | -24.22 m USD | -27.65 m USD | -12.48 m USD |
| Basic earnings per share | 0.02 USD/share | 0.04 USD/share | 0.1 USD/share | 0.12 USD/share | 0.06 USD/share |
| Diluted earnings per share | 0.02 USD/share | 0.04 USD/share | 0.1 USD/share | 0.12 USD/share | 0.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.